Showing results (61-70 of 131) with videos related to
Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|October 6, 2010
In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicidesYoussef Gali, Olivier Delezay, Joachim Brouwers, et al.Antiviral Therapy|May 4, 2005
Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cellsHarr F Njai, Paul J Lewi, Cornelus G M Janssen, et al.AIDS (London, England)|February 1, 2019
In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patientsPieter Pannus, Philipp Adams, Elisabeth Willems, et al.AIDS Research and Human Retroviruses|April 2, 2011
Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian populationIvan Best, Giovanni López, Michael Talledo, et al.Journal of Medical Virology|December 16, 2011
Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1Michael Talledo, Giovanni López, Jeroen R Huyghe, et al.Clinical & Developmental Immunology|July 31, 2012
Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responsesEllen Van Gulck, Nathalie Cools, Derek Atkinson, et al.Retrovirology|July 5, 2006
The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitnessHarr F Njai, Youssef Gali, Guido Vanham, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|January 22, 2009
Comparison of three ELISAs for the routine diagnosis of human T-lymphotropic virus infection in a high-prevalence setting in PeruKristien Verdonck, Elsa González, Fernando Maldonado, et al.Journal of Virology|July 19, 2013
Targeting of human antigen-presenting cell subsetsCleo Goyvaerts, Jozef Dingemans, Kurt De Groeve, et al.Bioorganic & Medicinal Chemistry Letters|October 23, 2012
Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agentsMuthusamy Venkatraj, Kevin K Ariën, Jan Heeres, et al.Pageof 14